A Relative Bioavailability Study of Valcyte (Valganciclovir) in Lung Transplant Recipients With or Without Cystic Fibrosis.
Condition(s):Cytomegalovirus InfectionsLast Updated:December 31, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Cytomegalovirus InfectionsLast Updated:December 31, 2015Completed
Condition(s):Cytomegalovirus InfectionsLast Updated:July 23, 2013Terminated
Condition(s):Congenital Cytomegalovirus Infection; Sensorineural Hearing LossLast Updated:June 18, 2015Terminated
Condition(s):Kidney Transplant Recipient; Heart Transplant RecipientLast Updated:May 25, 2016Completed
Condition(s):Lymphoid Malignancies; Lymphoproliferative DisordersLast Updated:August 1, 2011Terminated
Condition(s):Ulcerative Colitis, UnspecifiedLast Updated:June 7, 2023Recruiting
Condition(s):Kidney Transplant; Complications; CMVLast Updated:October 24, 2023Recruiting
Condition(s):Cytomegalovirus InfectionLast Updated:March 28, 2024Not yet recruiting
Condition(s):Cytomegalovirus Infections; Inflammatory Bowel DiseasesLast Updated:April 3, 2009Terminated
Condition(s):Cytomegalovirus InfectionLast Updated:September 11, 2006Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.